Short-term metformin and exercise training effects on strength, aerobic capacity, glycemic control, and mitochondrial function in children with burn injury

Eric Rivas, David Herndon, Craig Porter, Walter Meyer, Oscar Suman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Severely burned children experience a chronic state of sympathetic nervous system activation that is associated with hyper-metabolic/cardiac stress and muscle wasting. Metformin, a diabetes medication, helps control hyperglycemia in obese diabetic populations, and exercise has been shown to improve exercise strength and aerobic exercise capacity after severe burns. However, whether exercise improves glycemic control in burned children and whether combining exercise and metformin improves outcomes to a greater degree than exercise alone are unknown. We tested the hypothesis that a 6-wk exercise program combined with short-term metformin administration (E + M) improves aerobic and strength exercise capacity to a greater degree than exercise and placebo (E), while improving glucose tolerance and muscle metabolic function. We found that, before exercise training, the metformin group compared with the placebo group had attenuated mitochondrial respiration (pmol·s-1·mg-1) for each state: state 2 (-22.5 ± 3), state 3 (-42.4 ± 13), and oxphos (-58.9 ± 19) (P ≤ 0.02, M vs. E + M group for each state). However, in the E + M group, exercise increased mitochondrial respiration in each state (P ≤ 0.05), with respiration being comparable to that in the E group (each P > 0.05). In both groups, exercise induced comparable improvements Vin strength (change from preexercise, ∆1.6 ± 0.6 N-M·kgLBM) andO2peak (∆9 ± 7 mlO2·kgLBM) as well as fasting glucose (∆19.3 ± 13 mg·dl) and glucose AUC (∆3402 ± 3674 mg·dl-1·min-1), as measured by a 75-g OGTT (all P ≤ 0.03). Exercise reduced resting energy expenditure in E + M (∆539 ± 480 kcal/24 h, P < 0.01) but not E subjects (P = 0.68). Both groups exhibited reduced resting heart rate (∆30 ± 23 beats/min, P ≤ 0.02). These data indicate that short-term metformin combined with exercise provides no further improvement beyond that of exercise alone for strength, exercise capacity, and glycemic control.

Original languageEnglish (US)
Pages (from-to)E232-E240
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume314
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Metformin
Exercise
Wounds and Injuries
Respiration
Glucose
Placebos
Sympathetic Nervous System
Glucose Tolerance Test
Burns
Hyperglycemia
Energy Metabolism
Area Under Curve
Fasting
Myocardium
Heart Rate

Keywords

  • Exercise
  • Hypermetabolism
  • Pediatric burns

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this

Short-term metformin and exercise training effects on strength, aerobic capacity, glycemic control, and mitochondrial function in children with burn injury. / Rivas, Eric; Herndon, David; Porter, Craig; Meyer, Walter; Suman, Oscar.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 314, No. 3, 01.03.2018, p. E232-E240.

Research output: Contribution to journalArticle

@article{de02767e9e65429a984a69dbb723d659,
title = "Short-term metformin and exercise training effects on strength, aerobic capacity, glycemic control, and mitochondrial function in children with burn injury",
abstract = "Severely burned children experience a chronic state of sympathetic nervous system activation that is associated with hyper-metabolic/cardiac stress and muscle wasting. Metformin, a diabetes medication, helps control hyperglycemia in obese diabetic populations, and exercise has been shown to improve exercise strength and aerobic exercise capacity after severe burns. However, whether exercise improves glycemic control in burned children and whether combining exercise and metformin improves outcomes to a greater degree than exercise alone are unknown. We tested the hypothesis that a 6-wk exercise program combined with short-term metformin administration (E + M) improves aerobic and strength exercise capacity to a greater degree than exercise and placebo (E), while improving glucose tolerance and muscle metabolic function. We found that, before exercise training, the metformin group compared with the placebo group had attenuated mitochondrial respiration (pmol·s-1·mg-1) for each state: state 2 (-22.5 ± 3), state 3 (-42.4 ± 13), and oxphos (-58.9 ± 19) (P ≤ 0.02, M vs. E + M group for each state). However, in the E + M group, exercise increased mitochondrial respiration in each state (P ≤ 0.05), with respiration being comparable to that in the E group (each P > 0.05). In both groups, exercise induced comparable improvements Vin strength (change from preexercise, ∆1.6 ± 0.6 N-M·kgLBM) andO2peak (∆9 ± 7 mlO2·kgLBM) as well as fasting glucose (∆19.3 ± 13 mg·dl) and glucose AUC (∆3402 ± 3674 mg·dl-1·min-1), as measured by a 75-g OGTT (all P ≤ 0.03). Exercise reduced resting energy expenditure in E + M (∆539 ± 480 kcal/24 h, P < 0.01) but not E subjects (P = 0.68). Both groups exhibited reduced resting heart rate (∆30 ± 23 beats/min, P ≤ 0.02). These data indicate that short-term metformin combined with exercise provides no further improvement beyond that of exercise alone for strength, exercise capacity, and glycemic control.",
keywords = "Exercise, Hypermetabolism, Pediatric burns",
author = "Eric Rivas and David Herndon and Craig Porter and Walter Meyer and Oscar Suman",
year = "2018",
month = "3",
day = "1",
doi = "10.1152/ajpendo.00194.2017",
language = "English (US)",
volume = "314",
pages = "E232--E240",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Short-term metformin and exercise training effects on strength, aerobic capacity, glycemic control, and mitochondrial function in children with burn injury

AU - Rivas, Eric

AU - Herndon, David

AU - Porter, Craig

AU - Meyer, Walter

AU - Suman, Oscar

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Severely burned children experience a chronic state of sympathetic nervous system activation that is associated with hyper-metabolic/cardiac stress and muscle wasting. Metformin, a diabetes medication, helps control hyperglycemia in obese diabetic populations, and exercise has been shown to improve exercise strength and aerobic exercise capacity after severe burns. However, whether exercise improves glycemic control in burned children and whether combining exercise and metformin improves outcomes to a greater degree than exercise alone are unknown. We tested the hypothesis that a 6-wk exercise program combined with short-term metformin administration (E + M) improves aerobic and strength exercise capacity to a greater degree than exercise and placebo (E), while improving glucose tolerance and muscle metabolic function. We found that, before exercise training, the metformin group compared with the placebo group had attenuated mitochondrial respiration (pmol·s-1·mg-1) for each state: state 2 (-22.5 ± 3), state 3 (-42.4 ± 13), and oxphos (-58.9 ± 19) (P ≤ 0.02, M vs. E + M group for each state). However, in the E + M group, exercise increased mitochondrial respiration in each state (P ≤ 0.05), with respiration being comparable to that in the E group (each P > 0.05). In both groups, exercise induced comparable improvements Vin strength (change from preexercise, ∆1.6 ± 0.6 N-M·kgLBM) andO2peak (∆9 ± 7 mlO2·kgLBM) as well as fasting glucose (∆19.3 ± 13 mg·dl) and glucose AUC (∆3402 ± 3674 mg·dl-1·min-1), as measured by a 75-g OGTT (all P ≤ 0.03). Exercise reduced resting energy expenditure in E + M (∆539 ± 480 kcal/24 h, P < 0.01) but not E subjects (P = 0.68). Both groups exhibited reduced resting heart rate (∆30 ± 23 beats/min, P ≤ 0.02). These data indicate that short-term metformin combined with exercise provides no further improvement beyond that of exercise alone for strength, exercise capacity, and glycemic control.

AB - Severely burned children experience a chronic state of sympathetic nervous system activation that is associated with hyper-metabolic/cardiac stress and muscle wasting. Metformin, a diabetes medication, helps control hyperglycemia in obese diabetic populations, and exercise has been shown to improve exercise strength and aerobic exercise capacity after severe burns. However, whether exercise improves glycemic control in burned children and whether combining exercise and metformin improves outcomes to a greater degree than exercise alone are unknown. We tested the hypothesis that a 6-wk exercise program combined with short-term metformin administration (E + M) improves aerobic and strength exercise capacity to a greater degree than exercise and placebo (E), while improving glucose tolerance and muscle metabolic function. We found that, before exercise training, the metformin group compared with the placebo group had attenuated mitochondrial respiration (pmol·s-1·mg-1) for each state: state 2 (-22.5 ± 3), state 3 (-42.4 ± 13), and oxphos (-58.9 ± 19) (P ≤ 0.02, M vs. E + M group for each state). However, in the E + M group, exercise increased mitochondrial respiration in each state (P ≤ 0.05), with respiration being comparable to that in the E group (each P > 0.05). In both groups, exercise induced comparable improvements Vin strength (change from preexercise, ∆1.6 ± 0.6 N-M·kgLBM) andO2peak (∆9 ± 7 mlO2·kgLBM) as well as fasting glucose (∆19.3 ± 13 mg·dl) and glucose AUC (∆3402 ± 3674 mg·dl-1·min-1), as measured by a 75-g OGTT (all P ≤ 0.03). Exercise reduced resting energy expenditure in E + M (∆539 ± 480 kcal/24 h, P < 0.01) but not E subjects (P = 0.68). Both groups exhibited reduced resting heart rate (∆30 ± 23 beats/min, P ≤ 0.02). These data indicate that short-term metformin combined with exercise provides no further improvement beyond that of exercise alone for strength, exercise capacity, and glycemic control.

KW - Exercise

KW - Hypermetabolism

KW - Pediatric burns

UR - http://www.scopus.com/inward/record.url?scp=85043594721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043594721&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00194.2017

DO - 10.1152/ajpendo.00194.2017

M3 - Article

VL - 314

SP - E232-E240

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 3

ER -